Skip to main content

Biotech Belonged to the Bears in Second Half of 2021

A bearish sentiment in biotechnology took over in the second half of 2021, providing gains for the Direxion Daily S&P Biotech Bear 3X Shares (LABD). LABD climbed almost 21% in the second half of 2021, giving bearish biotech traders something to cheer about. Of course, it helps to have leverage...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.